Oberweis Asset Management Inc Insmed Inc Transaction History

Oberweis Asset Management Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Nov 14, 2018	SELL	$18.95 - $28.08 $200,870 - $297,648	-10,600 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$20.0 - $29.72 $212,000 - $315,032	10,600 New	10,600 $251,000
Q1 2018 May 15, 2018	SELL	$21.69 - $32.99 $216,900 - $329,900	-10,000 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$26.43 - $31.78 $44,931 - $54,026	1,700 Added 20.48%	10,000 $312,000
Q3 2017 Nov 13, 2017	BUY	$11.61 - $31.21 $96,363 - $259,043	8,300	8,300 $259,000

498

189M

3.21M

2.72M

Ticker INSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 135,476,992
Market Cap $9.9B
Description
Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...

Get notified when there are updates to the investment portfolio of Oberweis Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Oberweis Asset Management Inc with notifications on news.